Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
PERCEPTIVE ADVISORS LLC | 10% Owner | Dec 29 '23 | Buy | 7.24 | 115,774 | 838,204 | 7,099,182 | Dec 29 05:27 PM | PERCEPTIVE ADVISORS LLC | 10% Owner | Dec 28 '23 | Buy | 7.08 | 126,116 | 892,901 | 6,983,408 | Dec 29 05:27 PM | PERCEPTIVE ADVISORS LLC | 10% Owner | Dec 27 '23 | Buy | 7.20 | 79,726 | 574,027 | 6,857,292 | Dec 29 05:27 PM | PERCEPTIVE ADVISORS LLC | 10% Owner | Dec 26 '23 | Buy | 6.49 | 54,652 | 354,691 | 6,777,566 | Dec 26 07:21 PM | PERCEPTIVE ADVISORS LLC | 10% Owner | Dec 22 '23 | Buy | 6.67 | 250,000 | 1,667,500 | 6,722,914 | Dec 26 07:21 PM | PERCEPTIVE ADVISORS LLC | 10% Owner | Dec 21 '23 | Buy | 6.17 | 200,000 | 1,234,000 | 6,472,914 | Dec 26 07:21 PM | PERCEPTIVE ADVISORS LLC | 10% Owner | Dec 19 '23 | Buy | 5.36 | 277,008 | 1,484,763 | 6,272,914 | Dec 19 05:52 PM | PERCEPTIVE ADVISORS LLC | 10% Owner | Dec 18 '23 | Buy | 5.41 | 456,923 | 2,471,953 | 5,995,906 | Dec 19 05:52 PM | PERCEPTIVE ADVISORS LLC | 10% Owner | Dec 15 '23 | Buy | 5.97 | 500,000 | 2,985,000 | 5,538,983 | Dec 19 05:52 PM | Hayes Christopher G. | Chief Legal Officer | Nov 15 '23 | Sale | 2.97 | 11,558 | 34,327 | 123,226 | Nov 16 04:32 PM | White Ted | President and CEO | Nov 15 '23 | Sale | 2.97 | 11,558 | 34,327 | 170,090 | Nov 16 04:33 PM | Bonaccorso Joe | Chief Commercial Officer | Nov 15 '23 | Sale | 2.97 | 11,266 | 33,460 | 92,392 | Nov 16 04:49 PM | Kohler Terry | Chief Financial Officer | Nov 15 '23 | Sale | 2.97 | 9,632 | 28,607 | 34,416 | Nov 16 04:34 PM | Goldenberg Gary | Chief Medical Officer | Nov 15 '23 | Sale | 2.97 | 3,036 | 9,017 | 86,257 | Nov 16 04:35 PM | Hayes Christopher G. | Chief Legal Officer | Nov 14 '23 | Sale | 2.93 | 22,141 | 64,873 | 134,784 | Nov 16 04:32 PM | White Ted | President and CEO | Nov 14 '23 | Sale | 2.93 | 22,141 | 64,873 | 181,648 | Nov 16 04:33 PM | Bonaccorso Joe | Chief Commercial Officer | Nov 14 '23 | Sale | 2.93 | 21,580 | 63,229 | 103,658 | Nov 16 04:49 PM | Kohler Terry | Chief Financial Officer | Nov 14 '23 | Sale | 2.93 | 18,452 | 54,064 | 44,048 | Nov 16 04:34 PM | Goldenberg Gary | Chief Medical Officer | Nov 14 '23 | Sale | 2.93 | 5,817 | 17,044 | 89,293 | Nov 16 04:35 PM | Manning Paul B | Director | Jul 24 '23 | Buy | 5.02 | 200,000 | 1,004,000 | 7,851,128 | Jul 24 06:47 PM | White Ted | President and CEO | Jul 24 '23 | Sale | 4.83 | 50,677 | 244,770 | 128,789 | Jul 25 04:18 PM | Bonaccorso Joe | Chief Commercial Officer | Jul 24 '23 | Sale | 4.83 | 38,262 | 184,805 | 62,738 | Jul 25 04:22 PM | Hayes Christopher G. | Chief Legal Officer | Jul 24 '23 | Sale | 4.83 | 33,789 | 163,201 | 81,925 | Jul 25 04:25 PM | Goldenberg Gary | Chief Medical Officer | Jul 24 '23 | Sale | 4.83 | 28,699 | 138,616 | 70,110 | Jul 25 04:23 PM |
|